SAM
RPTX

Sectoral Asset Management’s Repare Therapeutics RPTX Stock Holding History

Sectoral Asset Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-237,785
Closed -$3.39M – 120
2022
Q1 		$3.39M Buy
237,785
+31,000
+15% +$460K 0.6% 64
2021
Q4 		$4.36M Sell
206,785
-309,700
-60% -$7.3M 0.66% 61
2021
Q3 		$13.6M Buy
516,485
+104,335
+25% +$3.37M 1.13% 27
2021
Q2 		$12.9M Buy
412,150
+402,150
+4,022% +$13.2M 1.04% 38
2021
Q1 		$307K Buy
+10,000
New +$340K 0.02% 108

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Sectoral Asset Management's RPTX Position: Q2 2022 in Review

Sectoral Asset Management sold out of Repare Therapeutics (RPTX) in Q2 2022, closing a stake of 237,785 shares — an estimated $3.39M sold.

Sectoral Asset Management first reported a position in RPTX in Q1 2021 and held it in 5 quarters. The position peaked at $13.6M in Q3 2021. 71 funds tracked by Wall St. Rank hold RPTX as of Q2 2022.

  • Sectoral Asset Management reported no remaining Repare Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Sectoral Asset Management sold 237,785 Repare Therapeutics shares in Q2 2022, an estimated $3.39M.
  • Sectoral Asset Management first reported a position in Repare Therapeutics in Q1 2021 and held it in 5 quarters.
  • Sectoral Asset Management's Repare Therapeutics position peaked at $13.6M in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2022.

Based on Sectoral Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.